Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype II”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Testing effectiveness (Phase 2)Study completedNCT03593447
What this trial is testing

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Testing effectiveness (Phase 2)Study completedNCT02332707
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 443
Post-approval studies (Phase 4)Ended earlyNCT05183828
What this trial is testing

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Washington 62
Testing effectiveness (Phase 2)Study completedNCT01648140
What this trial is testing

Dose Ranging of GSK2336805 in Combination Therapy

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 286
Testing effectiveness (Phase 2)Study completedNCT00621296
What this trial is testing

Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 15
Testing effectiveness (Phase 2)Study completedNCT00556504
What this trial is testing

The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C
TCM Biotech International Corp. 84
Testing effectiveness (Phase 2)Study completedNCT00036465
What this trial is testing

Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT02601573
What this trial is testing

Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Cirrhotic Subjects With Chronic Hepatitis C Virus (HCV) Genotype 3 (GT3) Infection (MK-5172-083)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 101
Testing effectiveness (Phase 2)UnknownNCT03133923
What this trial is testing

Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Who this might be right for
Epidemic Parotitis,Mumps
Institute of Medical Biology, Chinese Academy of Medical Sciences 1,080
Testing effectiveness (Phase 2)Study completedNCT01055821
What this trial is testing

Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients

Who this might be right for
Chronic Hepatitis C Infection
Transgene 140
Early research (Phase 1)UnknownNCT04961632
What this trial is testing

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 75
Testing effectiveness (Phase 2)Study completedNCT00984620
What this trial is testing

Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 160
Testing effectiveness (Phase 2)Study completedNCT01444521
What this trial is testing

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Study completedNCT02094443
What this trial is testing

Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option

Who this might be right for
Hepatitis CLiver Disease
Debiopharm International SA 52
Testing effectiveness (Phase 2)UnknownNCT01335711
What this trial is testing

CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects

Who this might be right for
Chronic Hepatitis C
ChronTech Pharma AB 32
Testing effectiveness (Phase 2)Study completedNCT01183169
What this trial is testing

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

Who this might be right for
Hepatitis C
Debiopharm International SA 459
Testing effectiveness (Phase 2)Study completedNCT02332720
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 413
Testing effectiveness (Phase 2)Study completedNCT01273948
What this trial is testing

Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection

Who this might be right for
Hepatitis C
Peregrine Pharmaceuticals 66
Testing effectiveness (Phase 2)Ended earlyNCT02777489
What this trial is testing

Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects

Who this might be right for
Obesity
Gene PreDiT 140
Testing effectiveness (Phase 2)Study completedNCT00277238
What this trial is testing

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
Hepatitis, Chronic Active
Pfizer 113
Next Page